ACET - adicetbio.com Qarzning balans kapitallashuviga nisbati

Adicet Bio, Inc. (ACET) grafik logotipi

Balans hisobotidagi dinamik moliyaviy leveraj tendentsiyasi Adicet Bio (ACET) tayyor hujayra mahsulotlarining rivojlanishini vizuallashtiradi. 0.12 qiymati aktivlarning bozor baholashuvi uchun bazaviy ko'rsatkich bo'lib xizmat qiladi. O'sish limfoma terapiyasi sinovlarini tezlashtirish uchun onkologiya markazlari bilan hamkorlik orqali qo'llab-quvvatlanmoqda, shu bilan birga kompaniya ekologik izini minimallashtirish uchun biomateriallarni utilizatsiya qilish qoidalariga qat'iy rioya qiladi.

ACET (Adicet Bio, Inc.) Qarzning balans qiymatiga nisbati tarixi 04.07.2022dan 27.10.2026gacha
adicetbio.com asosiy tovari

Institutsional kapital Adicet Bio (ACET) kompaniyasini kapital tuzilmasining barqarorligi prizmasi orqali baholaydi. Ushbu ko'rsatkich umumiy majburiyatlarni kapitalning balans qiymati bilan solishtirib, biznesning qarz mablag'lariga bog'liqlik darajasini aniqlaydi. Balansdagi moliyaviy leverajning dinamik tendentsiyasini tahlil qilish orqali investor moliyalashtirishning haqiqiy nisbatini ko'radi. Bioteknologiya sektori uchun ushbu xavf hujayralar terapiyasiga bo'lgan talab makroiqtisodiy sharoitlardan mustaqil qolishi bilan yumshatiladi. Qarz yuklamasining pastligi tadqiqot va ishlanmalar bosqichida aktivning ishonchliligini tasdiqlaydi.

Adicet Bio kimlar bilan raqobatlashadi

Balans kapitallashuviga qarzlar ARGX (argenx SE)|biontech.de - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati ABIVAX (ABVX)|ADMA: Qarzning sof aktivlarga nisbati|PTGX (Protagonist Therapeutics Inc) - Qarzning balans kapitallashuviga nisbati|Immunovant Therapeutics (IMVT) - Qarzning balans qiymatiga nisbati|KNSA (Kiniksa Pharmaceuticals) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar grifols.com (GRFS)|Adaptive Biotechnologies Corporation (ADPT) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Celldex Therapeutics Inc (CLDX)|Balans kapitallashuviga qarzlar AUPH|BioCryst Corp - Sof aktivlarga qarzlar|VERA: Qarzning balans kapitallashuviga nisbati|DNTH: Qarzning balans qiymatiga nisbati|PHVS (Pharvaris) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati AbCellera Bio|TRML (Tourmaline Corp) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar PGEN|Qarzning balans kapitallashuviga nisbati Pharming Group N.V. PHAR|Qarzning balans qiymatiga nisbati nektar.com (NKTR)|UPB: Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar Zenas Bio ZBIO|Immunome Corp - Balans kapitallashuviga qarzlar|GOSS - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar KalVista Pharmaceuticals|septerna.com (SEPN) - Qarzning balans qiymatiga nisbati|PVLA: Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar Savara Inc|Balans kapitallashuviga qarzlar RIGL (Rigel Pharmaceuticals Inc)|Qarzning balans qiymatiga nisbati AnaptysBio Inc. (ANAB)|ATXS: Balans kapitallashuviga qarzlar|ENGN - Balans qiymatiga qarzlar|Qarzning balans qiymatiga nisbati RAPT Therapeutics, Inc. RAPT|Aerovate Therapeutics Inc (JBIO) - Qarzning balans kapitaliga nisbati|Qarzning balans qiymatiga nisbati Aclaris ACRS|Kyverna Therapeutics, Inc (KYTX) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar Tiziana Life Sciences|Qarzning balans kapitallashuviga nisbati cabalettabio.com|VTYX (Ventyx Biosciences, Inc.) - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar THTX (Theratechnologies, Inc.)|AVTX: Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar Eledon Pharmaceuticals, Inc ELDN|Agenus - Balans kapitallashuviga qarzlar|CLYM - Balans kapitallashuviga qarzlar|ZURA (Zura Bio Limited) - Balans kapitallashuviga qarzlar|aTyr Pharma Inc (ATYR) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar ADAG (Adagene Inc)|Balans qiymatiga qarzlar Ikena Oncology, Inc. (IMA)|Qarzning balans qiymatiga nisbati Shattuck Labs, Inc.|Qarzning balans kapitaliga nisbati EQ (equilliumbio.com)|Connect Biopharma Holdings Limited (CNTB) - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati Immunic Therapeutics IMUX|Balans kapitallashuviga qarzlar Atara Biotherapeutics Inc (ATRA)|IFRX - Qarzning sof aktivlarga nisbati|XFOR: Balans kapitallashuviga qarzlar|CELU (Celularity) - Balans kapitallashuviga qarzlar|INMB - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati BRNS|Qarzning balans kapitallashuviga nisbati KZR (Kezar Life Sciences, Inc)|Qarzning balans qiymatiga nisbati SAB Biotherapeutics Inc (SABS)|Balans kapitallashuviga qarzlar AKTX (Akari Therapeutics)|ENLV - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati Q32 Bio Corp (QTTB)|GOVX - Qarzning sof aktivlarga nisbati|Edesa - Balans kapitallashuviga qarzlar|IBIO (iBio Corporation) - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati CARM|Qarzning balans qiymatiga nisbati XTLB|Qarzning balans kapitallashuviga nisbati BOLT (Bolt Biotherapeutics)|Qarzning balans qiymatiga nisbati hcwbiologics.com HCWB|Qarzning balans qiymatiga nisbati APVO (Aptevo Therapeutics Inc.)|AIM ImmunoTech, Inc. - Balans kapitallashuviga qarzlar|Aditxt Corp (ADTX) - Qarzning balans kapitallashuviga nisbati|GRI - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar XRTX|Vyome Holdings Inc. (HIND) - Balans qiymatiga qarzlar|REVB (Revelation Bio) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar Indaptus Corp|Balans kapitallashuviga qarzlar Scinai Immunotherapeutics SCNI|Qarzning balans qiymatiga nisbati calcimedica.com (CALI)|Balans kapitallashuviga qarzlar AFMD|Sof aktivlarga qarzlar Allakos Inc ALLK|HOOK: Balans kapitallashuviga qarzlar|IGMS - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar ITOS|Balans qiymatiga qarzlar oceanbiomedical.com|TC BioPharm (TCBP) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitaliga nisbati Third Harmonic Bio Inc. (THRD)